The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Data Protection Policy


Personal data

The protection of your data and the observance of your right of informational self-determination with regard to the collection, processing and use of your personal data are important to us.
CDDF will collect and store all personal data for the preparation and execution of the CDDF meetings. In accordance with data protection and other applicable laws, sensitive data will be deleted after the conference, whereas personal data, payment history and correspondence will be stored for the period prescribed by law (currently 7 years). As a rule CDDF will not store any credit card data.

Further use of your data

  • Newsletters, Announcements.

Your consent provided, the organiser can contact you with regular newsletters ahead and after the meeting, with an invitation to complete a post conference survey after the conference, as well as with announcements of future meetings. You may unsubscribe of these mailings at any time, this will not affect official correspondence from the conference secretariat.

  • Emailings on behalf of third parties

CDDF will not perform e-mailings to delegates on behalf of third parties. Email contact details of delegates will not be passed on to third parties in this context. CDDF will not share or sell your personal information to third parties.

-> You may unsubscribe of CDDF e-mailings list at any time.


  • Photographs

The Organiser may without the further consent of the participants use and release pictures taken during the Conference for reports of the Conference and/or in future marketing materials. By registering to this conference attendees agree that  photographs taken during the conference that could include recognizable images of those in attendance may be posted on the conference website. Names will not be published. The Conference is held in a public space, therefore we do not prohibit participants, exhibitors, sponsors, or news organisations from photographing, video or audio-taping some Conference activities. The organiser reserves the right to use images taken at the Conference with your photograph and/or likeness on social media and/or in future marketing materials. The organiser is NOT responsible for individual attendee’s use of your image or likeness.

  • List of meeting participants

In order to better organize breakout sessions of meetings and facilitate networking as well as active engagement, the organiser may share delegate lists containing names, affiliations and nationalities with registered participants and/or meeting chairs upon their request. By registering for meetings, attendees agree that their data can be included in the lists and shared with other meeting participants. The lists are for internal use only and not to be distributed to external parties.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70